Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin receptor partial agonists and GLP-1 analogues

Insulin receptor partial agonists and GLP-1 analogues

US Patent 10953076 · Granted Mar 23, 2021

Estimated economic value: $131,140,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-responsive insulin conjugates2025
Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc2023
Conjugate based systems for controlled insulin delivery2023
Tyrosine-specific functionalized insulin and insulin analogs2022
Conjugate based systems for controlled insulin delivery2022
Methods of treating diabetes by administering a glucagon receptor antagonist in 2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Insulin receptor partial agonists2020
Insulin receptor partial agonists2020
Insulin receptor partial agonists2020
Insulin receptor partial agonists2019